Third Strike For Gepirone ER: Fabre-Kramer/GSK Antidepressant “Not Approvable” Again
This article was originally published in The Pink Sheet Daily
Executive Summary
Antidepressant received two FDA “not approvable” letters when it was licensed to Organon.